BioRestorative Therapies, Inc. Price Today
BioRestorative Therapies, Inc.
BRTX
Healthcare
$9.20M
💰
Market Cap
0
💸
Price to Earnings
$-4.7
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
5 |
Strong Buy |
2 |
Hold |
1 |
Sell |
0 |
Strong Sell |
0 |
BRTX Price Forecast Target
2.0 👉 15.0 +661%
BRTX EPS Forecast
-4.7 👉 -2.5 +-47%
Financials
Profit Margin
0 %
Revenue Growth
-9.3 %
Dividend
$ 0
Held Percent
18.9% - Insiders
16.8% - Institutions
64.3% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $559,875.0
-
💰 Wealth Alliance $195,433.0
-
💰 Geode Capital Management, LLC $193,052.0
-
💰 Mariner, LLC $117,605.0
-
💰 Two Sigma Advisers, LP $115,983.0
Stock Ideas
Andreas Halvorsen Portfolio
Andreas Halvorsen is a Norwegian billionaire investor, hedge fund manager, and the founder of Viking Global Investors, a large hedge fund with over $50 billion in assets under management. He is known for his long-term, value-oriented investment appr…
Howard Marks Portfolio
Meet Howard Marks, the co-founder and lead of Oaktree Capital Management, a Los Angeles-based investment firm that manages roughly $78 billion in investment capital. Marks has an impressive background in distressed debt, high yield bonds, and conver…
Stanley Druckenmiller Portfolio
Stanley Druckenmiller is a legendary hedge fund manager who has made billions of dollars for his investors. His current portfolio is heavily invested in gold, silver, and other precious metals. He also owns shares in several technology and healthcar…
Chase Coleman Portfolio
Chase Coleman, the young and accomplished founder of Tiger Global, has made a significant impact in the investment world. With initial funding from Julian Robertson, Coleman's Tiger Global Management delivered impressive returns, including a remarka…📮FAQ
Some Frequently Asked Questions.
The BioRestorative Therapies, Inc. industry is Biotechnology
The BioRestorative Therapies, Inc. sector is Healthcare
The BioRestorative Therapies, Inc. forecasted predicted Price to Earnings PE ratio is -0.8
The BioRestorative Therapies, Inc. Price to Earnings PE ratio is 0
The Market Capitalization of BioRestorative Therapies, Inc. is $9.20M
There are total of 3384973 float shares with 16.8% held by Institutions and 18.9% held by insiders
The MBioRestorative Therapies, Inc. forecasted Earnings per Share EPS is $-2.5
The BioRestorative Therapies, Inc. Earnings per Share EPS is -4.7
The BioRestorative Therapies, Inc. company has $119800 gross profits with 0 profit margins
The BioRestorative Therapies, Inc. Earnings Growth is 0% with 0% quarterly earnings growth
The BioRestorative Therapies, Inc. Revenue is $128500 with -0.093 revenue growth
The price target for BioRestorative Therapies, Inc. stock is $15.0 for the high target and $10.0 for the low target
The consensus analyst recommendations for BioRestorative Therapies, Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for BioRestorative Therapies, Inc. is Buy, with the following breakdown:
- Buy: 5
- Strong Buy: 2
- Hold: 1
- Sell: 0
- Strong Sell: 0
The Beta of BioRestorative Therapies, Inc. is 61.4
The dividend of BioRestorative Therapies, Inc. is $0
The dividend yield of BioRestorative Therapies, Inc. is 0%
The biggest institutional and mutual fund holders of BioRestorative Therapies, Inc. stock are
- Vanguard Group Inc
- Wealth Alliance
- Geode Capital Management, LLC
- Mariner, LLC
The BioRestorative Therapies, Inc. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0